$PRE

AM Best Market Segment Report On Reinsurers

AM Best reports that a group of U.S. and Bermuda reinsurers maintained underwriting profitability in 2025, with a 16.8% net return on equity, despite slower premium growth. The composite includes seven companies, such as Arch Capital and Everest Group. Profitability was supported by higher investment income, but growth slowed to less than 1.0% due to market softening. AM Best expects muted growth in 2026 amid declining rates in property and casualty lines.

Original reporting
Published Sep 1, 2026, 10:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 10:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AM Best Market Segment Report On Reinsurers — source image
Decision brief

The 30-second read

$PREBearishLow
01

Why it matters

Provides sector‑wide profitability metrics and growth outlook, but no single company catalyst.

02

Market read

Highlights steady underwriting performance in the reinsurance sector, useful for investors monitoring insurance‑linked securities.

03

What to watch

Potential impact of the 2026 Atlantic hurricane season and rate declines could alter the outlook.

Relevance 4/10Novelty 5/10Timing: report released Sep 1 2026

Background

The article summarizes a new AM Best market segment report covering U.S. and Bermuda reinsurers.

Company-level read

Ticker impact

$PREBearishMedium confidence
Context

PartnerRe is part of the composite showing a 1.7‑point combined‑ratio deterioration.

Expected impact

Potential modest downside as combined ratio worsens.

Evidence & confidence

Combined‑ratio change is a new data point but limited in isolation.

$RNRNeutralMedium confidence
Context

RenaissanceRe Holdings is included in the composite with stable ROE and soft premium growth.

Expected impact

Little to no short‑term impact.

Evidence & confidence

Sector data reinforces existing expectations.

Market effects

Reinsurance sector shows sustained profitability despite soft premium growth, suggesting resilience.

U.S. and Bermuda reinsurers may influence broader insurance market sentiment.

AM Best's composite may be referenced by global investors assessing reinsurance risk.

Counterpoint

Investors could argue that muted premium growth signals upcoming pressure on margins, warranting caution.

Key entities

  • AM Best

    Publisher of the reinsurance market segment report.

Related articles

$PREMed

Prenetics Global Ltd (PRE): Financial results for Q2 2026

Prenetics Global Ltd (PRE) furnished an SEC Form 6-K — earnings release. Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results Cumulative Personal Investment by Leadership Since November 2025 Reaches Approximately $3.75 Million NEW YORK, N.Y. – Aug. 26, 2026 (GLOBE NEWSWIRE) – Prenetics Global L

$PREMed

Prenetics (PRE) Q2 2026 Earnings Call Transcript

Prenetics (PRE) reported Q2 2026 revenue of $46.5M, up 29% from Q1 and 3.9x from a year ago, with IM8 contributing $45M. The company raised its full-year revenue guidance to $220M-$230M and initiated 2027 guidance of $400M+. July saw record revenue of $20.9M and a 21% drop in customer acquisition cost. PRE expects Q3 to be its first positive cash flow quarter and plans to launch new products in Q4 and Q1 2027.

$PREMed

Prenetics Global Q2 Earnings Call Highlights

Prenetics (NASDAQ:PRE) reported preliminary July revenue of $21.4M, including about $20.9M from IM8, and said it reached its highest monthly level. Q2 added 118,000 new IM8 customers (140,000 active subscribers). Q2 gross profit was $30.2M (65% margin); adjusted EBITDA loss was $19M. It expects H2 2026 adjusted EBITDA loss of $8M to $12M and a first positive quarter on an adjusted free-cash-flow basis with a $1B General Catalyst facility.

$PREHighAI 9/10

Prenetics Global Limited: Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million; July Was the First Month of Positive Consolidated Adjusted

Prenetics Global (NASDAQ: PRE) reported Q2 2026 revenue of $46.5 million, up about 288% YoY, and IM8 revenue of $45.0 million, up about 359% YoY. Results were within guidance. The company raised FY 2026 total revenue guidance to $220-230 million and initiated FY 2027 IM8 revenue guidance of $400 million+.

$PREMed

PartnerRe records $447m in first-half net income

PartnerRe reported first-half 2026 net income of $447 million, down from $493 million a year earlier, with operating income of $689 million and annualised operating ROE of 12.6%. Gross premiums written rose to $5.42 billion. Non-life underwriting profit was $396 million with a 85.1% combined ratio. Investment income increased to $491 million, but unrealised losses reduced net investment return.

$RNRMed

RenRe posts net income of $654m for second quarter

RenaissanceRe reported Q2 net income available to common shareholders of $654.2m, up on underwriting performance, higher investment income, and continued capital returns. Book value per share rose 5.7% to $264.77. Underwriting profit was $599.1m with a 72.8% combined ratio. Net investment income increased 4.7% to $432.5m. The company repurchased $350m of common shares.